Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Alimonte

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Brachytherapy|December 4, 2014
The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancerLaura D'Alimonte, Joelle Helou, Christopher Sherman, et al.
Brachytherapy|October 11, 2022
Opioid consumption and pain in patients with gynecological cancer who underwent spinal anesthesia vs. general anesthesia for interstitial brachytherapyGordon E Locke, Lucas C Mendez, Kevin Martell, et al.
Frontiers in Oncology|September 14, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective TrialsHarvey C Quon, Hima Bindu Musunuru, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2014
Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapyEvelyn Elias, Joelle Helou, Liying Zhang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 18, 2014
Educating our patients collaboratively: a novel interprofessional approachRebecca Reinhart, Laura D'Alimonte, Kari Osmar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 2019
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trialYasir Alayed, Laura D'Alimonte, Joelle Helou, et al.
Brachytherapy|October 15, 2018
A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D eraLucas C Mendez, Pencilla Lang, Chirag Patel, et al.
Technical Innovations & Patient Support in Radiation Oncology|December 31, 2025
Beyond the first course: Re-irradiation practices in Ontario - Insights from a provincial surveyBrian Liszewski, Timothy P Hanna, Nareesa Ishmail, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomyJennifer Wong, Laura D'Alimonte, Jan Angus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomesAndrew Loblaw, Patrick Cheung, Laura D'Alimonte, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Brachytherapy|December 4, 2014
The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancerLaura D'Alimonte, Joelle Helou, Christopher Sherman, et al.
Brachytherapy|October 11, 2022
Opioid consumption and pain in patients with gynecological cancer who underwent spinal anesthesia vs. general anesthesia for interstitial brachytherapyGordon E Locke, Lucas C Mendez, Kevin Martell, et al.
Frontiers in Oncology|September 14, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective TrialsHarvey C Quon, Hima Bindu Musunuru, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2014
Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapyEvelyn Elias, Joelle Helou, Liying Zhang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 18, 2014
Educating our patients collaboratively: a novel interprofessional approachRebecca Reinhart, Laura D'Alimonte, Kari Osmar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 2019
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trialYasir Alayed, Laura D'Alimonte, Joelle Helou, et al.
Brachytherapy|October 15, 2018
A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D eraLucas C Mendez, Pencilla Lang, Chirag Patel, et al.
Technical Innovations & Patient Support in Radiation Oncology|December 31, 2025
Beyond the first course: Re-irradiation practices in Ontario - Insights from a provincial surveyBrian Liszewski, Timothy P Hanna, Nareesa Ishmail, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomyJennifer Wong, Laura D'Alimonte, Jan Angus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomesAndrew Loblaw, Patrick Cheung, Laura D'Alimonte, et al.
Pageof 5